Doha, Qatar: As part of its humanitarian efforts to alleviate the suffering of patients with cancer in Syria, Qatar Red Crescent Society (QRCS) has launched a new project to provide costly chemotherapy, immunotherapy, and hormonal drugs for patients with cancer at oncology centers in northern Syria.

The give-month project responds to the significant gap in specialized health care services in northern Syria, exacerbated by the prolonged conflict and unaffordable prices of cancer drugs.

Hopefully, it will help reduce mortality rates and health complications among patients with cancer and ease the burden on local health care facilities by reducing the need to refer patients for treatment abroad.

Under the project, essential cancer drugs such as chemotherapy and immunotherapy, will be supplied, distributed, and examined for quality in coordination with the World Health Organization (WHO) and the health directorates in Idlib and Aleppo.

These supplies are expected to directly benefit 112 patients with cancer over the five-month period, in addition to 560 indirect beneficiaries from the families of patients and the local community.

In a statement, Mohamed Bader Al-Sada, Assistant Secretary-General for Relief and International Development at QRCS, said,“Given the high mortality rates and limited resources, there remains a need for more support to address the gap and provide early detection and treatment services for various types of cancer”.

Al-Sada revealed preparations for a new project to provide chemotherapy and immunotherapy drugs for 400 displaced and poor patients with cancer at oncology centers in Syria.

He called on the benevolent donors to lend a hand in creating a new hope for patients with cancer, by donating via the project's webpage ( or calling the home donation collection number (33998898).

“A donation of just QR10,000 can save the life of a patient, after years of suffering and pain from cancer,” he emphasized.

This intervention builds on a previous project, implemented by QRCS in 2024, to provide drugs and medical supplies for more than 900 patients with cancer. It also involved supporting cancer treatment centers with medical equipment and training for health care personnel.

Cancer in Syria continues to be a significant public health concern, exacerbated by years of conflict and its impact on health care infrastructure and access to treatment. Despite efforts to rebuild and strengthen cancer care services, shortages of essential medications, limited access to specialized treatment facilities, and lack of comprehensive cancer screening programs remain major challenges.

MENAFN11082025000063011010ID1109910619